.jpg)
Fagron Sterile Services US Launches RFID enabled products to support patient safety and hospital inventory management; joins Kit Check at the First Annual Medication Intelligence Summit
Virtual summit will bring together healthcare executives, experts, and pharmacists to discuss hospital pharmacy operation trends and more.
WICHITA, KS – May, 12, 2022 – Fagron Sterile Services US (FSS), a leader in 503B outsourcing and part of Fagron, the global leader in pharmaceutical compounding, today announced the commercial availability of select presentations of Radio Frequency Identification (RFID) enabled ready-to-administer operating room syringes.
“We look forward to delivering the additional value that RFID-tagged syringes provide to our customers, for medication safety and medication management. This portfolio highlights FSS’s focus on customer needs and our continued innovation,” said Jason McGuire, Vice President of Operations, Fagron North America.
Visit fagronsterile.com/kit-check to request a free consultation and the latest in product availability.
.jpg)
FSS will join Kit Check, the industry leader in Medication Intelligence™ solutions for hospitals, at the first annual Medication Intelligence Summit from June 6-8, 2022. The virtual event will bring together pharmaceutical experts from across the industry to discuss topics across three important tracks: inventory management, drug diversion monitoring, and pharmacy purchasing.
This summit will feature thought-provoking discussions on issues such as medication tracking gaps, pharmacy purchasing trends, drug shortages, and drug diversion, as well as informative continuing education (CE)webinars certified through the Michigan Pharmacists Association.
“Following our recent FSS facility expansion announcement, partnering with Kit Check to support patient safety and medication management is yet another exciting example of our commitment to producing reliable, high-quality medication solutions for our customers and the patients they serve.” Andrew Pulido, President, Fagron North America.
Building on key collaborations between organizations such as Fagron and Kit Check, the summit promises to elevate industry leaders’ knowledge about drug and pharmacy trends in order to address industry pain points and curb drug diversion.
“By hosting this Summit annually and bringing together featured healthcare leaders from diverse clinical backgrounds and experiences, we can facilitate delivering strategies and technologies to address the industry’s most pressing issues on a wide-ranging scale,” said Kevin MacDonald, co-founder and CEO of Kit Check.
The virtual summit will be hosted via Zoom and available on Kit Check’s Medication Intelligence Center webpage once it has concluded. For more information or to register for the summit, visit Kit Check’s event page.
Kit Check and Fagron Partner to Launch RFID-tagged 503B Products in February 2022
503B Compounder Set to Manufacture Products Embedded with RFID tags Compatible with Kit Check Scanning Technology
ARLINGTON, VA – December 08, 2021 – Kit Check, the market leader in software solutions for item-level visibility in the pharmaceutical space, in collaboration with Fagron Sterile Services US (FSS), a leading 503B manufacturer, is pleased to announce that Radio Frequency Identification (RFID)-tagged products will be available in United States hospitals in February 2022.
Medications labeled with RFID tags at the manufacturer level ensures that there is item-level visibility of drug products throughout their dynamic lifecycle. This means better patient safety, optimized inventory for hospitals, cost savings, and dramatically increased workflow simplicity and efficiency.
RFID tags, in combination with the Kit Check technology, store information for each dose, including expiration date, lot number, NDC, and refrigeration date, so restocking, inventory management, and managing shortages and recalls is as seamless as possible. COVID-19 has continued to shine a light on the importance of item-level inventory management in the hospital, with Kit Check customers well poised to deal with the difficulty inventory challenges the pandemic has caused.
“We are so excited to be able to offer RFID-tagged medications for our hospital customers, and even more excited to be working with Fagron to expand the offering of pre-tagged 503B products,” said Kevin MacDonald, CEO and Co-Founder of Kit Check.
Talk to your dedicated Account Representative or request a free consultation to learn more today.
About Fagron
Fagron is a global group of innovative pharmaceutical companies focused on creating the future of personalizing medicine. As the world’s leading pharmaceutical compounding company serving 60 countries, Fagron combines local expertise with global innovation. Fagron North America is fully integrated with facilities specializing in 503A Compounding, 503B Outsourcing and providing pharmacists with raw ingredients, supplies, education, and technical support.
Fagron Sterile Services US (FSS) offers exceptional service to health systems, hospitals, ambulatory surgery centers and physician offices in need of reliable 503B Outsourcing for critical care, labor and delivery, pain management, ophthamlics (including Avastin®), and other specialty medication like the only sterile LET gel.
About Kit Check
Kit Check is the leading provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management. Our groundbreaking medication intelligence platforms provide item level visibility, workflow simplicity and actionable analytics, empowering stakeholders to deliver the right medicine to the right patient at the right time, every time. To date, our more than 500 U.S. and Canadian hospital partners have tracked more than 100 million medications using Kit Check’s RFID product. Bluesight™ for Controlled Substances software is currently in use in more than 100 hospitals including full health system implementations, with more than 11 million cases tracked, and was ranked #1 in the Drug Diversion Monitoring category in the 2019 Best in KLAS report. More information about Kit Check and our software solutions can be found at kitcheck.com.
.jpg)
